Growth Rates of Human Stomach Cancer

Hepatocyte Growth Factor/c-Met Signaling in Regulating Urokinase Plasminogen Activator in Human Stomach Cancer: A Potential Therapeutic Target for Human Stomach Cancer

BACKGROUND Up-regulation of the hepatocyte growth factor (HGF), its transmembrane tyrosine kinase receptor (c-Met), and urokinase type plasminogen activator (uPA), is associated with the development and metastasis of various types of cancers. However, the mechanisms by which HGF/c-Met signaling mediates cancer progression and metastasis are unclear. METHODS We investigated the roles of HGF/c-...

Epidemiology and trend of stomach cancer mortality in Iran

Background and aims: Stomach cancer is one of the most common cancers and the second cause of deaths among cancers worldwide cancer in the world. This study aimed to estimate the rate and trend of death from stomach cancer in Iranian population between 2006 and 2010. Methods: This study was a cross-sectional conducted using mortality data in Iranian popul...

Cancer of the Stomach

Infrequent loss of chromosomal heterozygosity in human stomach cancer.

By molecular genetic approach using polymorphic DNA markers which detect allelic deletion at specific chromosomal loci, we analyzed 30 human stomach cancers for possible loss of chromosomal heterozygosity. We analyzed 25 loci on 18 different chromosomes covering regions frequently deleted in several types of cancers. Loss of chromosomal heterozygosity was observed only in five of 30 cases exami...

Cancer of the Stomach

Carcinoma of the stomach, although its incidence is decreasing in the United States, is still a fatal disease. The results today are actually no better than they were 30 years ago because we are still making late diagnoses. In order to improve our results in the treatment of cancer of the stomach, we must perform fiberoptic gastroscopy in individuals over age 40 who have gastric complaints that...